ADMA Biologics
ADMA
#3174
Rank
A$7.05 B
Marketcap
A$29.57
Share price
-1.26%
Change (1 day)
-0.45%
Change (1 year)

Market capitalization of ADMA Biologics (ADMA)

Market cap: A$7.05 Billion

As of December 2025 ADMA Biologics has a market cap of A$7.05 Billion. This makes ADMA Biologics the world's 3174th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ADMA Biologics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025A$7.05 B6.4%
2024A$6.63 B342.37%
2023A$1.49 B19.03%
2022A$1.25 B230.72%
2021A$0.38 B58.83%
2020A$0.23 B-29.25%
2019A$0.33 B115.51%
2018A$0.15 B-15.61%
2017A$0.18 B103.56%
2016A$91.53 M-22.87%
2015A$0.11 B-6.42%
2014A$0.12 B56.08%
2013A$81.25 M

End of Day market cap according to different sources

On Dec 7th, 2025 the market cap of ADMA Biologics was reported to be:

A$7.12 Billion
by Nasdaq info icon info icon
A$7.14 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novavax
NVAX
A$1.65 B-76.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$13.81 B 95.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A$77.9 M-98.90%๐Ÿ‡บ๐Ÿ‡ธ USA